Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) Knowledge in Senior Dental and Medical Students. [PDF]
Develi T, Akgok MG, Wardak M.
europepmc +1 more source
Risk factors for denosumab-related osteonecrosis of the jaw: a pharmacovigilance study using the U.S. FDA adverse event reporting system database. [PDF]
Bai H +5 more
europepmc +1 more source
Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw: reply to Subramanian and Quek [PDF]
Javier Narváez
openalex +1 more source
Resource utilization in cancer patients with bisphosphonate-associated osteonecrosis of the jaw. [PDF]
Najm MS +3 more
europepmc +1 more source
Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis [PDF]
María Eugenia Sarasquete +13 more
openalex +1 more source
Low-Level Laser Therapy in the Management of Bisphosphonate-Related Osteonecrosis of the Jaw. [PDF]
Bitonti V +6 more
europepmc +1 more source
Medication-related osteonecrosis of the jaw primary prevention: multidomain long-term intervention versus pre-bisphosphonate treatment standalone dental intervention. A retrospective multi-center comparative cohort study. [PDF]
Mauceri R +14 more
europepmc +1 more source
A multicenter study of CT findings in medication-related osteonecrosis of the jaw. [PDF]
Otsuru M +22 more
europepmc +1 more source

